Press release
Coronary Stents Market Report- Insights on Growth Trends, Top Players, Types, Applications and Regional Analysis
The Coronary Stents Market research report also enables us to understand the market’s competitive landscape and new product development, expansion, and acquisition. In addition, Coronary Stents Market also provides information about leading market players, their mergers & acquisitions, market share, recent developments, etc.Get FREE PDF Sample of the Report @
https://www.reportsnreports.com/contacts/requestsample.aspx?name=4998931
Coronary Stents Market Report provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents.
Scope of this Report-
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy this Report-
Coronary Stents Market Report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=4998931
Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Stents Overview
3 Products under Development
3.1 Coronary Stents - Pipeline Products by Stage of Development
3.2 Coronary Stents - Pipeline Products by Segment
3.3 Coronary Stents - Pipeline Products by Territory
3.4 Coronary Stents - Pipeline Products by Regulatory Path
3.5 Coronary Stents - Pipeline Products by Estimated Approval Date
3.6 Coronary Stents - Ongoing Clinical Trials
4 Coronary Stents - Pipeline Products under Development by Companies
4.1 Coronary Stents Companies - Pipeline Products by Stage of Development
4.2 Coronary Stents - Pipeline Products by Stage of Development
5 Coronary Stents Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adcomp Technologies Inc. Company Overview
5.2.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Bifurcation Systems Inc Company Overview
5.3.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Aeon Bioscience Company Overview
5.4.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
5.5 AlviMedica Medical Technologies Inc Company Overview
5.5.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Amaranth Medical Inc Company Overview
5.6.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Atrium Medical Corp Company Overview
5.7.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Axordia Ltd (Inactive) Company Overview
5.8.1 Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 B. Braun Melsungen AG Company Overview
5.9.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
5.10 Bactiguard Holding AB Company Overview
5.10.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
5.11 Bionext Biotech Products Ltd. Company Overview
5.11.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Biosensors International Group Ltd Company Overview
5.12.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Biosten, LLC Company Overview
5.13.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 AG Company Overview
5.14.1 AG Pipeline Products & Ongoing Clinical Trials Overview
5.15 SE & Co KG Company Overview
5.15.1 SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.16 Biotyx Medical Company Overview
5.16.1 Biotyx Medical Pipeline Products & Ongoing Clinical Trials Overview
5.17 Boston Scientific Corp Company Overview
5.17.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 Cardionovum GmbH Company Overview
5.18.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.19 Cardiorev Pte Ltd (Inactive) Company Overview
5.19.1 Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.20 Columbia University Company Overview
5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Concept Medical Inc Company Overview
5.21.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Contego Medical LLC Company Overview
5.22.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Cordis Corp Company Overview
5.23.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.24 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.24.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.25 DISA Vascular (Pty) Ltd Company Overview
5.25.1 DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.26 Elixir Medical Corp Company Overview
5.26.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.27 Envision Scientific Pvt Ltd Company Overview
5.27.1 Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
5.28.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.29 I.B.S. S.p.A. Company Overview
5.29.1 I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Icon Interventional Systems, Inc. Company Overview
5.30.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 ID Nest Medical SAS Company Overview
5.31.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
5.32 InspireMD Inc Company Overview
5.32.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Japan Stent Technology Co., Ltd. Company Overview
5.33.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.34 JW Medical Systems Ltd Company Overview
5.34.1 JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Kaneka Corp Company Overview
5.35.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
5.36 Kyoto Medical Planning Co Ltd Company Overview
5.36.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 Liaoning Biomedical Materials R&D Center Co Ltd Company Overview
5.37.1 Liaoning Biomedical Materials R&D Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.38 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.38.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 MangoGen Pharma Inc Company Overview
5.39.1 MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Manli Cardiology Ltd Company Overview
5.40.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Medinol Ltd Company Overview
5.41.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Medlogics Device Corp (Inactive) Company Overview
5.42.1 Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.43 Medtronic Plc Company Overview
5.43.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.44 Meril Life Sciences Pvt Ltd Company Overview
5.44.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.45 Miami Cardiovascular Innovations Company Overview
5.45.1 Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview
5.46 Micell Technologies Inc Company Overview
5.46.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Michigan Technological University Company Overview
5.47.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.48 MicroPort Scientific Corp Company Overview
5.48.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.49 Minvasys SAS Company Overview
5.49.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
5.50 MIV Therapeutics Inc Company Overview
5.50.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 NanoCoeur, Inc. Company Overview
5.51.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.52 Nanova, Inc Company Overview
5.52.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.53 National University of Ireland Galway Company Overview
5.53.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
5.54 Nesstent Ltd. Company Overview
5.54.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.55 Nexeon MedSystems Inc Company Overview
5.55.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 North Carolina State University Company Overview
5.56.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.57 Northwestern University Company Overview
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.58 NuVascular Technologies Inc Company Overview
5.58.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.59 OrbusNeich Company Overview
5.59.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.60 Palmaz Scientific Inc (Inactive) Company Overview
5.60.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.61 Pediastent LLC Company Overview
5.61.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
5.62 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.62.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.63 Qvanteq AG Company Overview
5.63.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
5.64 Relisys Medical Devices Ltd Company Overview
5.64.1 Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.65 REVA Medical Inc Company Overview
5.65.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.66 Rontis AG Company Overview
5.66.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
5.67 S3V Vascular Technologies Company Overview
5.67.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.68 Sahajanand Medical Technologies Pvt Ltd Company Overview
5.68.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.69 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.69.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.70 Sino Medical Sciences Technology Inc Company Overview
5.70.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.71 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.72 Stentys SA Company Overview
5.72.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
5.73 Svelte Medical Systems Inc Company Overview
5.73.1 Svelte Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.74 Tepha Inc Company Overview
5.74.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.75 Terumo Corp Company Overview
5.75.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.76 Terumo Interventional Systems Company Overview
5.76.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.77 TissueGen Inc Company Overview
5.77.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.78 Tremedics Medical Devices LLC Company Overview
5.78.1 Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
5.79 TrendyMED Inc. Company Overview
5.79.1 TrendyMED Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.80 University of Alabama at Birmingham Company Overview
5.80.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
5.81 University of Colorado Company Overview
5.81.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.82 University of Florida Company Overview
5.82.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.83 University of Michigan Company Overview
5.83.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.84 University of Strathclyde Company Overview
5.84.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.85 University of Utah Company Overview
5.85.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.86 VasoTech Inc. Company Overview
5.86.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.87 Viller Scientific LLC Company Overview
5.87.1 Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.88 Vornia Biomaterials Ltd Company Overview
5.88.1 Vornia Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.89 Xenogenics Corporation Company Overview
5.89.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
6 Coronary Stents- Recent Developments
7 Appendix
7.1 Methodology
and more...
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Stents Market Report- Insights on Growth Trends, Top Players, Types, Applications and Regional Analysis here
News-ID: 2492699 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Overview
Workwear Industry Overview, Analysis, Futuristic Trend, Segmentation Overview By …
According to a new report published by Allied Market Research, titled, "Workwear Market," The Workwear Market Size was valued at $16.2 billion in 2021, and is estimated to reach $29.1 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
➡️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 & 𝐓𝐎𝐂 : https://www.alliedmarketresearch.com/request-sample/17239
The workwear market is meant to provide the products such as corporate workwear, industrial workwear, and uniforms with upper ware &…
Growlers Industry Overview, Analysis, Futuristic Trend, Segmentation Overview By …
The Growlers Market Size was valued at $456.8 million in 2021, and is projected to reach $791.1 million by 2031, growing at a CAGR of 5.4% from 2022 to 2031. A growler is a draught beer container made of glass, ceramic, or stainless steel that is mostly used in the United States, Canada, Australia, Brazil, and other nations. Breweries and brewpubs frequently sell them to customers who want to purchase…
Qwaiting Launches Queue Overview Per Time & Queue Overview Per Day Report
Qwaiting is excited to share its new tools: the Queue Overview per Time & Queue Overview per Day report. It helps businesses in calculating how long the customers spend on queuing and how useful the service flow is.
Through these reports, businesses can observe how the various queues run throughout the day. As per these reports businesses can make the right decisions about the number of staff they require. It helps…
Oriented Strand Board Metals Market Overview 2024-2033: Outlook and Overview
"The new report published by The Business Research Company, titled Oriented Strand Board Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the oriented strand board market size has grown rapidly in recent years. It will grow from…
Umbrella Market : Industry Overview, Analysis, Futuristic Trend, Segmentation Ov …
Umbrella also is known as parasol is an object used for protection against rain and sunlight. Umbrellas are usually designed for protection from rain whereas parasol is specifically designed and used to block the sunlight. Umbrellas are hand-held portable devices which come in different sizes, shapes, colors, and designs. These have been used since the seventeenth century and are considered as an essential accessory by most of the people. Canopy,…
Hotels Market : Industry Overview, Analysis, Futuristic Trend, Segmentation Over …
The hotel industry is a subset of the hospitality industry that focuses on providing lodging services to consumers. There are many different sorts of hotels, which can be classified on the basis of their size, function, service, and pricing. Limited-service, mid-range service, and full-service are the three most common levels of services. Some customers, on the other hand, may be more familiar with the star rating system, in which one…
